Trifluoperazine induces cellular apoptosis by inhibiting autophagy and targeting NUPR1 in multiple myeloma

Multiple myeloma (MM) is the second most common hematologic malignancy of immunoglobulin‐secreting plasma cells. Recent modern combination therapies have improved survival rates, but many patients develop resistance to novel drugs, leading to relapse. Trifluoperazine (TFP), a typical antipsychotic d...

Full description

Bibliographic Details
Main Authors: Anmao Li, Xuanxin Chen, Zizi Jing, Jianbin Chen
Format: Article
Language:English
Published: Wiley 2020-10-01
Series:FEBS Open Bio
Subjects:
Online Access:https://doi.org/10.1002/2211-5463.12960
_version_ 1828174619756986368
author Anmao Li
Xuanxin Chen
Zizi Jing
Jianbin Chen
author_facet Anmao Li
Xuanxin Chen
Zizi Jing
Jianbin Chen
author_sort Anmao Li
collection DOAJ
description Multiple myeloma (MM) is the second most common hematologic malignancy of immunoglobulin‐secreting plasma cells. Recent modern combination therapies have improved survival rates, but many patients develop resistance to novel drugs, leading to relapse. Trifluoperazine (TFP), a typical antipsychotic drug, has been reported to exert antitumor effects by targeting various pathways. Thus far, the role of TFP in MM has not been elucidated. In the current study, we demonstrated that TFP inhibited cell growth and autophagy activity but induced apoptosis of U266 and RPMI 8226 MM cells. Furthermore, cotreatment of these cell lines with TFP and rapamycin, a potent autophagy inducer, reduced cell apoptosis compared with TFP treatment alone. We also found that TFP inhibited nuclear protein 1 (NUPR1) expression. In the presence of TFP, cells stably overexpressing NUPR1 showed a higher viability than cells treated with the nonspecific control. Autophagy suppression and apoptosis induction caused by TFP were also reversed in MM cells upon NUPR1 overexpression. Overall, our results indicate that in the context of MM, TFP targets NUPR1, inhibiting cell growth and inducing apoptosis by autophagy inhibition. Our results could contribute toward efforts for the development of more effective therapies for MM to be tested in future clinical trials.
first_indexed 2024-04-12T04:15:39Z
format Article
id doaj.art-642fc25d382d4ee6816bf22ac0231f26
institution Directory Open Access Journal
issn 2211-5463
language English
last_indexed 2024-04-12T04:15:39Z
publishDate 2020-10-01
publisher Wiley
record_format Article
series FEBS Open Bio
spelling doaj.art-642fc25d382d4ee6816bf22ac0231f262022-12-22T03:48:25ZengWileyFEBS Open Bio2211-54632020-10-0110102097210610.1002/2211-5463.12960Trifluoperazine induces cellular apoptosis by inhibiting autophagy and targeting NUPR1 in multiple myelomaAnmao Li0Xuanxin Chen1Zizi Jing2Jianbin Chen3Department of Hematology the First Affiliated Hospital of Chongqing Medical University Yuzhong ChinaDepartment of Hematology the First Affiliated Hospital of Chongqing Medical University Yuzhong ChinaDepartment of Hematology the First Affiliated Hospital of Chongqing Medical University Yuzhong ChinaDepartment of Hematology the First Affiliated Hospital of Chongqing Medical University Yuzhong ChinaMultiple myeloma (MM) is the second most common hematologic malignancy of immunoglobulin‐secreting plasma cells. Recent modern combination therapies have improved survival rates, but many patients develop resistance to novel drugs, leading to relapse. Trifluoperazine (TFP), a typical antipsychotic drug, has been reported to exert antitumor effects by targeting various pathways. Thus far, the role of TFP in MM has not been elucidated. In the current study, we demonstrated that TFP inhibited cell growth and autophagy activity but induced apoptosis of U266 and RPMI 8226 MM cells. Furthermore, cotreatment of these cell lines with TFP and rapamycin, a potent autophagy inducer, reduced cell apoptosis compared with TFP treatment alone. We also found that TFP inhibited nuclear protein 1 (NUPR1) expression. In the presence of TFP, cells stably overexpressing NUPR1 showed a higher viability than cells treated with the nonspecific control. Autophagy suppression and apoptosis induction caused by TFP were also reversed in MM cells upon NUPR1 overexpression. Overall, our results indicate that in the context of MM, TFP targets NUPR1, inhibiting cell growth and inducing apoptosis by autophagy inhibition. Our results could contribute toward efforts for the development of more effective therapies for MM to be tested in future clinical trials.https://doi.org/10.1002/2211-5463.12960apoptosisautophagymultiple myelomanuclear protein 1trifluoperazine
spellingShingle Anmao Li
Xuanxin Chen
Zizi Jing
Jianbin Chen
Trifluoperazine induces cellular apoptosis by inhibiting autophagy and targeting NUPR1 in multiple myeloma
FEBS Open Bio
apoptosis
autophagy
multiple myeloma
nuclear protein 1
trifluoperazine
title Trifluoperazine induces cellular apoptosis by inhibiting autophagy and targeting NUPR1 in multiple myeloma
title_full Trifluoperazine induces cellular apoptosis by inhibiting autophagy and targeting NUPR1 in multiple myeloma
title_fullStr Trifluoperazine induces cellular apoptosis by inhibiting autophagy and targeting NUPR1 in multiple myeloma
title_full_unstemmed Trifluoperazine induces cellular apoptosis by inhibiting autophagy and targeting NUPR1 in multiple myeloma
title_short Trifluoperazine induces cellular apoptosis by inhibiting autophagy and targeting NUPR1 in multiple myeloma
title_sort trifluoperazine induces cellular apoptosis by inhibiting autophagy and targeting nupr1 in multiple myeloma
topic apoptosis
autophagy
multiple myeloma
nuclear protein 1
trifluoperazine
url https://doi.org/10.1002/2211-5463.12960
work_keys_str_mv AT anmaoli trifluoperazineinducescellularapoptosisbyinhibitingautophagyandtargetingnupr1inmultiplemyeloma
AT xuanxinchen trifluoperazineinducescellularapoptosisbyinhibitingautophagyandtargetingnupr1inmultiplemyeloma
AT zizijing trifluoperazineinducescellularapoptosisbyinhibitingautophagyandtargetingnupr1inmultiplemyeloma
AT jianbinchen trifluoperazineinducescellularapoptosisbyinhibitingautophagyandtargetingnupr1inmultiplemyeloma